ロード中...
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
Pharmacogenetic testing is a useful and increasingly widespread tool to assist in antidepressant prescription. More than ten antidepressants (including tricyclics, selective serotonin reuptake inhibitors and venlafaxine) have already genetic biomarkers of response/side effects in clinical guidelines...
保存先:
| 出版年: | Clin Psychopharmacol Neurosci |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean College of Neuropsychopharmacology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006978/ https://ncbi.nlm.nih.gov/pubmed/31958900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|